Groupe la Francaise’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$171M Buy
143,142
+10,966
+8% +$11.2M 2.06% 9
2026
Q1
$121M Sell
132,176
-3,566
-3% -$3.62M 1.66% 12
2025
Q4
$145M Sell
135,742
-48,839
-26% -$46.7M 2.03% 13
2025
Q3
$139M Buy
184,581
+3,770
+2% +$2.81M 1.88% 14
2025
Q2
$141M Buy
180,811
+72,332
+67% +$56.2M 2.28% 10
2025
Q1
$89M Sell
108,479
-2,900
-3% -$2.41M 1.89% 13
2024
Q4
$89M Buy
+111,379
New +$92.2M 2.2% 10

Other funds holding LLY

Groupe la Francaise's LLY Position: Q2 2026 in Review

Groupe la Francaise increased its Eli Lilly (LLY) stake by 8.3% in Q2 2026, buying an estimated $11.2M and bringing the position to 143,142 shares worth $171M. The position accounts for 2.06% of the portfolio, ranked #9.

Groupe la Francaise first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Groupe la Francaise held 143,142 shares of Eli Lilly worth $171M as of Q2 2026.
  • Groupe la Francaise bought 10,966 Eli Lilly shares in Q2 2026, an estimated $11.2M.
  • Eli Lilly made up 2.06% of Groupe la Francaise's portfolio in Q2 2026, its #9 holding.
  • Groupe la Francaise first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.